Egyptian International Pharmaceutical Industries Co. (PHAR) Net Income
Net Income
EGP 1.44B
Trailing 12 months (TTM)
As of 23 Jul 2026, 19:29 (Cairo time)
Net income is the profit remaining after all operating costs, interest and taxes are deducted from revenue — the bottom line of the income statement. A negative figure means the company recorded a loss for that fiscal year.
Net income history
| Fiscal year | Net income | YoY growth | Net margin |
|---|---|---|---|
| 2025 | 1.44B | 31.57% | 15.27% |
| 2024 | 1.1B | 33.25% | 14.44% |
| 2023 | 822.32M | 27.89% | 15.72% |
| 2022 | 642.98M | 31.83% | 16.26% |
| 2021 | 487.75M | 0.25% | 14.31% |
| 2020 | 486.51M | -27.45% | 16.86% |
| 2019 | 670.63M | -4.28% | 19.66% |
| 2018 | 700.63M | 1.78% | 24.88% |
| 2017 | 688.36M | 41.2% | 27.24% |
| 2016 | 487.49M | 31.32% | 24.76% |
| 2015 | 371.22M | 15.89% | 21.88% |
| 2014 | 320.32M | 2.47% | 20.3% |
| 2013 | 312.59M | 2.15% | 23.03% |
| 2012 | 306.01M | -3.51% | 24.39% |
| 2011 | 317.16M | -7.11% | 27.23% |
| 2010 | 341.43M | 14.54% | 30.77% |
| 2009 | 298.1M | 16.17% | 29.68% |
| 2008 | 256.61M | 10.64% | 28.2% |
| 2007 | 231.93M | 18.01% | 27.28% |
| 2006 | 196.54M | — | 26.37% |
All monetary figures in EGP. Source: Egyptian Exchange via TradingView; annual figures from company disclosures; updated weekly. Prices refresh every 15 minutes during EGX trading hours.